ProciseDx point-of-care platform for inflammatory bowel disease (MIB302)
NICE has developed a medtech innovation briefing (MIB) on ProciseDx point-of-care platform for inflammatory bowel disease
Search results
16 results for ibd
-
-
The Insides System for managing intestinal failure (MIB286)
NICE has developed a medtech innovation briefing (MIB) on The Insides System for managing intestinal failure
-
Immunoscore for predicting risk of colon cancer relapse (MIB269)
NICE has developed a medtech innovation briefing on Immunoscore for predicting risk of colon cancer relapse
-
Manchester Royal Infirmary Virtual Biologics Clinic
gastroenterology and dermatology, including at an event for the National IBD audit. Implementing up-to-date high-quality research...
-
Colonoscopic surveillance in adults with Ulcerative colitis, Crohn's disease or adenomas - Is this happening?
and over with ulcerative colitis or Crohn's disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to...
-
eXroid for internal haemorrhoids (MIB201)
NICE has developed a medtech innovation briefing (MIB) on eXroid for internal haemorrhoids
-
PredictSure-IBD for inflammatory bowel disease prognosis (MIB178)
We have temporarily withdrawn this medtech innovation briefing to update the information with regard to further research in this area.
-
The New Faecal Calprotectin Care Pathway
guidance DG11, for the detection of inflammation in the bowel (i.e. IBS vs IBD). Uptake of this guidance has previously been poor and...
-
Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease (MIB132)
NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory
-
RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease (MIB109)
NICE has developed a medtech innovation briefing (MIB) on RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease
-
Implementing faecal calprotectin testing in primary care
option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD) or irritable bowel...
-
Evaluation of guidelines for the use of faecal calprotectin testing in primary care
cancer is not suspected and it is used to support a diagnosis of inflammatory bowel disease (IBD) or irritable bowel...
-
Therapeutic Review- A NICE way to optimise prescribing
use of: - Biologics in Rheumatoid Arthritis(RA), Psoriasis & Inflammatory Bowel Disease (IBD) using NICE algorithms &...
-
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection
-
Pouchitis: rifaximin (ESUOM30)
Summary of the evidence on rifaximin for treating pouchitis to inform local NHS planning and decision-making
-
Chronic anal fissure: botulinum toxin type A injection (ESUOM14)
Summary of the evidence on botulinum toxin type A injection for treating chronic anal fissure to inform local NHS planning and decision-making